We examined expression of GNA12 in relation to the molecular classification and phenotypic characteristics of glioma samples, including consideration of their IDH1/p53/PTEN mutational status, tumor grade, patient age, and survival. The gene discussed is TP53; the disease is central nervous system cancer.